CMRA logo

CMRA EBITDA

Annual EBITDA

-$17.89 M
-$12.52 M-233.42%

December 31, 2022


Summary


Performance

CMRA EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCMRAprofitabilitymetrics:

Quarterly EBITDA

-$2.12 M
-$742.00 K-53.66%

September 30, 2023


Summary


Performance

CMRA Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCMRAprofitabilitymetrics:

TTM EBITDA

-$8.88 M
+$915.60 K+9.34%

September 30, 2023


Summary


Performance

CMRA TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCMRAprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

CMRA EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-233.4%0.0%0.0%
3 y3 years-777.9%0.0%0.0%
5 y5 years-777.9%0.0%0.0%

CMRA EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-233.4%at low-53.7%+76.6%-82.2%+50.3%
5 y5-year-777.9%at low-137.5%+76.6%-348.6%+50.3%
alltimeall time-777.9%at low-137.5%+76.6%-348.6%+50.3%

Comera Life Sciences Holdings EBITDA History

DateAnnualQuarterlyTTM
Sep 2023
-
-$2.12 M(+53.7%)
-$8.88 M(-9.3%)
Jun 2023
-
-$1.38 M(-43.5%)
-$9.80 M(-43.9%)
Mar 2023
-
-$2.45 M(-16.6%)
-$17.48 M(-2.3%)
Dec 2022
-$17.89 M
-$2.93 M(-3.6%)
-$17.89 M(+5.5%)
Sep 2022
-
-$3.04 M(-66.5%)
-$16.96 M(+14.5%)
Jun 2022
-
-$9.06 M(+217.5%)
-$14.81 M(+91.6%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$2.85 M(+42.7%)
-$7.73 M(+58.6%)
Dec 2021
-$5.37 M(+163.3%)
-
-
Dec 2021
-
-$2.00 M(+123.6%)
-$4.88 M(+69.6%)
Sep 2021
-
-$894.50 K(-54.8%)
-$2.88 M(+45.2%)
Jun 2021
-
-$1.98 M
-$1.98 M
Dec 2020
-$2.04 M
-
-

FAQ

  • What is Comera Life Sciences Holdings annual EBITDA?
  • What is the all time high annual EBITDA for Comera Life Sciences Holdings?
  • What is Comera Life Sciences Holdings annual EBITDA year-on-year change?
  • What is Comera Life Sciences Holdings quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Comera Life Sciences Holdings?
  • What is Comera Life Sciences Holdings quarterly EBITDA year-on-year change?
  • What is Comera Life Sciences Holdings TTM EBITDA?
  • What is the all time high TTM EBITDA for Comera Life Sciences Holdings?
  • What is Comera Life Sciences Holdings TTM EBITDA year-on-year change?

What is Comera Life Sciences Holdings annual EBITDA?

The current annual EBITDA of CMRA is -$17.89 M

What is the all time high annual EBITDA for Comera Life Sciences Holdings?

Comera Life Sciences Holdings all-time high annual EBITDA is -$2.04 M

What is Comera Life Sciences Holdings annual EBITDA year-on-year change?

Over the past year, CMRA annual EBITDA has changed by -$12.52 M (-233.42%)

What is Comera Life Sciences Holdings quarterly EBITDA?

The current quarterly EBITDA of CMRA is -$2.12 M

What is the all time high quarterly EBITDA for Comera Life Sciences Holdings?

Comera Life Sciences Holdings all-time high quarterly EBITDA is -$894.50 K

What is Comera Life Sciences Holdings quarterly EBITDA year-on-year change?

Over the past year, CMRA quarterly EBITDA has changed by $0.00 (0.00%)

What is Comera Life Sciences Holdings TTM EBITDA?

The current TTM EBITDA of CMRA is -$8.88 M

What is the all time high TTM EBITDA for Comera Life Sciences Holdings?

Comera Life Sciences Holdings all-time high TTM EBITDA is -$1.98 M

What is Comera Life Sciences Holdings TTM EBITDA year-on-year change?

Over the past year, CMRA TTM EBITDA has changed by $0.00 (0.00%)